AIM
TMO icon

Advantage Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Advantage Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$270K Sell
928
-59
-6% -$16.9K 0.21% 86
2019
Q2 		$290K Sell
987
-20
-2% -$5.51K 0.22% 89
2019
Q1 		$276K Sell
1,007
-92
-8% -$22.9K 0.22% 92
2018
Q4 		$246K Buy
1,099
+83
+8% +$19.5K 0.19% 92
2018
Q3 		$248K Buy
1,016
+105
+12% +$24.2K 0.16% 106
2018
Q2 		$189K Sell
911
-7
-0.8% -$1.49K 0.14% 135
2018
Q1 		$190K Hold
918
– – 0.07% 165
2017
Q4 		$174K Sell
918
-71
-7% -$13.6K 0.05% 198
2017
Q3 		$187K Buy
989
+139
+16% +$25.2K 0.06% 179
2017
Q2 		$148K Buy
850
+2
+0.2% +$336 0.05% 191
2017
Q1 		$130K Sell
848
-36
-4% -$5.5K 0.05% 195
2016
Q4 		$125K Buy
884
+500
+130% +$73.7K 0.05% 192
2016
Q3 		$61K Sell
384
-518
-57% -$79.8K 0.02% 293
2016
Q2 		$133K Buy
902
+32
+4% +$4.72K 0.06% 184
2016
Q1 		$123K Hold
870
– – 0.05% 188
2015
Q4 		$123K Sell
870
-5
-0.6% -$667 0.06% 197
2015
Q3 		$107K Sell
875
-31
-3% -$4.04K 0.06% 208
2015
Q2 		$118K Buy
906
+464
+105% +$60.5K 0.06% 210
2015
Q1 		$59K Sell
442
-711
-62% -$91.7K 0.03% 305
2014
Q4 		$144K Buy
+1,153
New +$140K 0.11% 153

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advantage Investment Management's TMO Position: Q3 2019 in Review

Advantage Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 6% in Q3 2019, selling an estimated $16.9K and leaving 928 shares worth $270K. The position accounts for 0.21% of the portfolio, ranked #86.

Advantage Investment Management first reported a position in TMO in Q4 2014 and has held it in 20 quarters since. The position peaked at $290K in Q2 2019. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Advantage Investment Management held 928 shares of Thermo Fisher Scientific worth $270K as of Q3 2019.
  • Advantage Investment Management sold 59 Thermo Fisher Scientific shares in Q3 2019, an estimated $16.9K.
  • Thermo Fisher Scientific made up 0.21% of Advantage Investment Management's portfolio in Q3 2019, its #86 holding.
  • Advantage Investment Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Thermo Fisher Scientific position peaked at $290K in Q2 2019.
  • 1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.